WCM Investment Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-63,604
Closed -$10.6M 283
2025
Q4
$10.6M Sell
63,604
-4,395
-6% -$688K 0.02% 147
2025
Q3
$8.44M Sell
67,999
-41,865
-38% -$5.09M 0.02% 149
2025
Q2
$13.6M Buy
109,864
+6,872
+7% +$874K 0.03% 131
2025
Q1
$13.7M Buy
102,992
+5,906
+6% +$909K 0.04% 119
2024
Q4
$14M Sell
97,086
-2,072
-2% -$297K 0.03% 132
2024
Q3
$14.5M Buy
99,158
+32,126
+48% +$4.61M 0.03% 126
2024
Q2
$8.49M Sell
67,032
-22,584
-25% -$3.54M 0.02% 147
2024
Q1
$16.5M Sell
89,616
-40,338
-31% -$7.68M 0.04% 113
2023
Q4
$24.1M Buy
129,954
+5,248
+4% +$817K 0.07% 80
2023
Q3
$19.9M Sell
124,706
-2,167
-2% -$354K 0.06% 73
2023
Q2
$18M Buy
126,873
+1,538
+1% +$247K 0.05% 88
2023
Q1
$21.1M Sell
125,335
-1,476,647
-92% -$263M 0.07% 70
2022
Q4
$271M Buy
1,601,982
+82,356
+5% +$14.9M 0.9% 36
2022
Q3
$290M Buy
1,519,626
+168,299
+12% +$35.5M 1.04% 32
2022
Q2
$224M Sell
1,351,327
-41,290
-3% -$6.53M 0.8% 37
2022
Q1
$262M Buy
1,392,617
+30,708
+2% +$5.83M 0.73% 37
2021
Q4
$361M Buy
1,361,909
+51,297
+4% +$13.8M 0.81% 33
2021
Q3
$379M Buy
1,310,612
+1,247,690
+1,983% +$320M 0.88% 29
2021
Q2
$12.6M Buy
62,922
+20,087
+47% +$3.9M 0.03% 95
2021
Q1
$8.33M Buy
42,835
+31
+0.1% +$6.36K 0.02% 120
2020
Q4
$8.2M Sell
42,804
-14,783
-26% -$2.69M 0.02% 127
2020
Q3
$8.5M Buy
57,587
+1,498
+3% +$214K 0.03% 101
2020
Q2
$6.93M Buy
56,089
+3,977
+8% +$468K 0.03% 109
2020
Q1
$5.03M Buy
52,112
+14,576
+39% +$1.41M 0.03% 102
2019
Q4
$3.47M Buy
37,536
+27,484
+273% +$2.31M 0.02% 133
2019
Q3
$771K Buy
+10,052
New +$879K ﹤0.01% 131

Other funds holding RGEN

WCM Investment Management's RGEN Position: Q1 2026 in Review

WCM Investment Management sold out of Repligen (RGEN) in Q1 2026, closing a stake of 63,604 shares — an estimated $10.6M sold.

WCM Investment Management first reported a position in RGEN in Q3 2019 and held it in 26 quarters. The position peaked at $379M in Q3 2021. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • WCM Investment Management reported no remaining Repligen position as of Q1 2026 after selling out during the quarter.
  • WCM Investment Management sold 63,604 Repligen shares in Q1 2026, an estimated $10.6M.
  • WCM Investment Management first reported a position in Repligen in Q3 2019 and held it in 26 quarters.
  • WCM Investment Management's Repligen position peaked at $379M in Q3 2021.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on WCM Investment Management's 13F filing for Q1 2026, filed 7 May 2026.